Global Minimally Invasive Vertebral Compression Fracture Repair Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. VCFs
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Technology
08.1 Global Vertebroplasty Market
08.1.1 Market Size and Forecast
08.1.2 Global Vertebroplasty Market by Number of Procedures
08.2 Global Kyphoplasty Market
08.2.1 Market Size and Forecast
08.2.2 Global Kyphoplasty Market by Number of Procedures
09. Complications Associated with Vertebroplasty and Kyphoplasty
10. Cost Analysis
11. Reimbursement Scenario
11.1 Reimbursement Scenario in US
11.1.1 Codes and Payments for Outpatient Procedures (Hospitals)
11.1.2 Codes and Payment for Outpatient Procedures at ASC
11.1.3 Physician Payments for Procedures Performed at Hospital or ASC
11.1.4 Physician Payments for Procedures Performed in a Physician Office (Non-facility Setting)
11.2 Reimbursement Scenario in Other Major Countries
11.2.1 UK
11.2.2 Germany
11.2.3 Spain
11.2.4 Italy
11.2.5 France
11.2.6 Japan
12. Geographical Segmentation
12.1 Minimally Invasive VCF Repair Market in Americas
12.1.1 Market Size and Forecast
12.2 Minimally Invasive VCF Repair Market in EMEA
12.2.1 Market Size and Forecast
12.3 Minimally Invasive VCF Repair Market in APAC
12.3.1 Market Size and Forecast
13. Key Leading Countries
13.1 US
13.2 Germany
13.3 Japan
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and Their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and Their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Alphatec
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2014
22.1.4 Business Strategy
22.1.5 Recent Developments
22.1.6 SWOT Analysis
22.2 CareFusion Corp.
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Business Strategy
22.2.7 Key Information
22.2.8 SWOT Analysis
22.2.9 Strengths
22.2.10 Weaknesses
22.2.11 Opportunities
22.2.12 Threats
22.3 DePuy Synthes
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Strategy
22.3.5 Recent Developments
22.3.6 SWOT Analysis
22.4 Medtronic
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Key Products
22.4.4 Business Segmentation by Revenue 2014
22.4.5 Cardiac and Vascular Group Segmentation by Revenue 2014
22.4.6 Restorative Therapies Group Segmentation by Revenue 2014
22.4.7 Diabetes Group Segmentation by Revenue 2014
22.4.8 Business Segmentation by Revenue 2013 and 2014
22.4.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
22.4.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
22.4.11 Diabetes Group Segmentation by Revenue 2013 and 2014
22.4.12 Geographical Segmentation by Revenue 2014
22.4.13 Business Strategy
22.4.14 Key Developments
22.4.15 SWOT Analysis
22.5 Stryker
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue 2013
22.5.6 Business Strategy
22.5.7 Recent Developments
22.5.8 SWOT Analysis
22.6 Zimmer Holdings
22.6.1 Key Facts
22.6.2 Business Overview
22.6.3 Business Segmentation by Revenue 2013
22.6.4 Business Segmentation by Revenue 2012 and 2013
22.6.5 Geographical Segmentation by Revenue 2013
22.6.6 Business Strategy
22.6.7 Recent Developments
22.6.8 SWOT Analysis
23. Other Reports in this Series